ACE inhibition reduces left ventricular mass independent of pressure without affecting coronary flow and flow reserve in spontaneously hypertensive rats

American Journal of the Medical Sciences

Volumn 314, Issue 1, 1997, Pages 21-27

  Kaneko, Kazuhiro ^a   Susic, Dinko ^a   Nunez, Eduardo ^a   Frohlich, Edward D ^a  

^a OCHSNER MEDICAL CENTER   (United States)

Author keywords

Angiotensin converting enzyme inhibitor; Coronary circulation; Left ventricular hypertrophy; Regional hemodynamics

Indexed keywords

RAMIPRIL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIHYPERTENSIVE ACTIVITY; ARTERY RESISTANCE; ARTICLE; CORONARY ARTERY BLOOD FLOW; DOSE RESPONSE; DRUG EFFECT; ENZYME INHIBITION; HEART INDEX; HEART LEFT VENTRICLE HYPERTROPHY; HYPERTENSION; MALE; NONHUMAN; ORAL DRUG ADMINISTRATION; RAT; SPONTANEOUSLY HYPERTENSIVE RAT;

EID: 0030738790     PISSN: 00029629     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000441-199707000-00005     Document Type: Article

References (42)

1. Frohlich ED, Apstein C, Chobanian AV, Devereux RB, Dustan HP, Dzau V, et al. The heart in hypertension. N Engl J Med. 1992;327:998-1008.
2. Pegram BL, Ishise S, Frohlich ED. Effects of methyldopa, clonidine and hydralazine on cardiac mass and hemodynamics in Wistar-Kyoto and spontaneously hypertensive rats. Circ Res. 1982;16:40-6.
3. Frohlich Ed, Sasaki O, Chien Y, Arita M. Changes in cardiovascular mass, left ventricular pumping ability and aortic distensibility after calcium antagonists in Wistar-Kyoto and spontaneously hypertensive rats. J Hypertens. 1992; 10:1369-78.
4. Frohlich ED, Horinaka S. Cardiac and aortic effects of angiotensin converting enzyme inhibitors. Hypertension. 1991;18(suppl 2):2-7.
5. Susic D, Frohlich ED. Left ventricular hypertrophy: A pathophysiological and molecular biological perspective. Hypertens Res. 1993;16:163-77.
6. Kaneko K, Susic D, Nunez E, Frohlich ED. Losartan reduces cardiac mass and improves coronary flow reserve in the spontaneously hypertensive rat. J Hypertens. 1996;14: 645-53.
7. Pfeffer MA, Pfeffer JM, Frohlich ED. Pumping ability of the hypertrophied left ventricle of the spontaneously hypertensive rat. Circ Res. 1976;38:423-9.
8. Pfeffer MA, Pfeffer JM, Frohlich ED. Cardiac function and morphology with aging in the spontaneously hypertensive rat. Am J Physiol. 1979;237:H461-8.
9. Dellsperger KC, Marcus ML. Effects of left ventricular hypertrophy on the coronary circulation. Am J Cardiol. 1990;65:1504-10.
10. Tomanek RJ. Response of the coronary vasculature to myocardial hypertrophy. J Am Coll Cardiol. 1990;15:528-33.
11. Linz W, Schaper J, Wiemer G, Albus U, Schoelkens BA. Ramipril prevents left ventricular hypertrophy with myocardial fibrosis without blood pressure reduction: A one year study in rats. Br J Pharmacol. 1992;107:970-5.
12. Gohlke P, Linz W, Schölkens BA, Kuwer T, Bortenbach S, Schnell A, et al. Angiotensin-converting enzyme inhibition improves cardiac function. Role of bradykinin. Hypertension. 1994;23:411-8.
13. Rhaleb N-E, Yang X-P, Scicli AG, Carretero OA. Role of kinins and nitric oxide in the antihypertrophic effect of ramipril. Hypertension. 1994;23(part 2):856-68.
14. Timmermans PBMWM, Chiu AT, Herblin WF, Wong PC, Smith RD. Angiotensin II receptor subtypes. Am J Hypertens. 1992;5:406-10.
15. Nasjletti A, Colina-Chourio J, McGiff JC. Disappearance of bradykinin in the renal circulation of dogs. Circ Res. 1975;37:59-65.
16. Mimran A, Targhett R, Laroche B. The hypertensive effects of captopril: Evidence for an influence of kinins. Hypertension. 1980;2:732-7.
17. Swartz SL, Williams GH, Hollenberg NK, Levine L, Dluhy RG, More JC. Captopril-induced changes in prostaglandin production: Relationship to vascular responses in normal man. J Clin Invest. 1980;65:1257-64.
18. Scicli AG. Increases in cardiac kinins as a new mechanism to protect the heart. Hypertension. 1994;23:419-21.
19. Soria F, Frohlich ED, Aristizabal D, Kaneko K, Kardon MB, Hunter J, Pegram BL. Preserved cardiac performance after quinapril-induced left ventricular mass reversal in spontaneously hypertensive rats. J Hypertens. 1994;12:585-9.
20. Ishise S, Pegram BL, Yamamoto J, Kitamura Y, Frohlich ED. Cardiac output and blood flow in conscious rats. Am J Physiol. 1980;239:H443-9.
21. Kobrin I, Kardon MB, Oigman W, Pegram BL, Frohlich ED. Role of site of microsphere injection and catheter position on systemic and regional hemodynamics in rat. Am J Physiol. 1984;247:H35-9.
22. Ando K, Frohlich ED, Chein Y, Pegram BL. Effects of quinapril on systemic and regional hemodynamics and cardiac mass in spontaneously hypertensive and Wistar-Kyoto rats. J Vasc Med Biol. 1991;3:117-23.
23. Pfeffer MA, Pfeffer JM, Dunn FG, Nishiyama K, Tsuchiya M, Frohlich ED. Natural biventricular hypertrophy in normotensive rats. I. Physical and hemodynamic characteristics. Am J Physiol. 1973;236:H640-3.
24. Sesoko S, Pegram BL, Kuwajima I, Frohlich ED. Hemodynamic studies in spontaneously hypertensive rats with congenital arteriovenous shunts. Am J Physiol. 1982;242: H722-5.
25. Wangler RD, Peters KG, Marcus ML, Tomanek RJ. Effects of duration and severity of arterial hypertension and cardiac hypertrophy on coronary vasodilator reserve. Circ Res. 1982;51:10-8.
26. Tomanek RJ, Wangler RD, Bauer CA. Prevention of coronary vasodilator reserve decrement in spontaneously hypertensive rats. Hypertension. 1985;7:533-40.
27. Sugishita Y, Lida K, Yukisada K, Ito I. Cardiac determinants of regression of left ventricular hypertrophy in essential hypertension with antihypertensive treatment. J Am Coll Cardiol. 1990;15:665-71.
28. Pfeffer MA, Pfeffer JM. Pharmacological regression of cardiac hypertrophy in experimental hypertension. J Cardiovasc Pharmacol. 1984;6:865-9.
29. Frohlich ED, Iwata R, Sasaki O. Clinical and physiological significance of local renin-angiotensin system. Am J Med. 1989;87:19-23.
30. Dzau VJ, Re RN. Evidence of existence of renin in the heart. Circulation. 1989;75(suppl 1):134-6.
31. Lindpainter K, Ganten D. The cardiac renin-angiotensin system: An appraisal of present experimental and clinical evidence. Circ Res. 1991;68:905-21.
32. Morgan HE, Baker KM. Cardiac hypertrophy: Mechanical, neural, and endocrine dependence. Circulation. 1991;83: 13-25.
33. 1] angiotensin II receptor-mediated stimulation of protein synthesis in chick heart cells. Am J Physiol. 1990;258:H806-13.
34. Waspe LE, Ordahl CP, Simpson PC. The cardiac betamyosin heavy chain isogene is induced selectively in alpha 1-adrenergic receptor-stimulated hypertrophy of cultured rat heart myocytes. J Clin Invest. 1990;85:1206-14.
35. Komura I, Shibazaki Y, Kurabayashi M, Takaku F, Yazaki Y. Molecular cloning of gene sequences from rat heart rapidly responsive to pressure overload. Circ Res. 1990;66: 979-85.
36. Marban E, Koretsune Y. Cell calcium, oncogenes, and hypertrophy. Hypertension. 1990;15:652-8.
37. Linz W, Hennig R, Scholkens BA. Role of angiotensin II receptor antagonism and converting enzyme inhibition in the progression and regression of cardiac hypertrophy in rats. J Hypertens. 1991;9(suppl 6):S400-1.
38. Unger T, Torsten M, Lamberty V, et al. Effect of early onset angiotensin converting enzyme inhibition on myocardial capillaries. Hypertension. 1992;20:478-82.
39. Strauer B, Schwartzkopff B, Motz W, Vogt M. Coronary vascular changes in the progression and regression of hypertensive heart disease. J Cardiovasc Pharmacol. 1991;18(suppl 3): S20-7
40. Clozel JP, Véniant M, Hess P, Sprecher U. Effects of two angiotensin converting enzyme inhibitors and hydralazine on coronary circulation in hypertensive rats. Hypertension. 1991;18(suppl 2):8-14.
41. Anderson PG, Bishop SP, Digerness SB. Vascular remodeling and improvement of coronary reserve after hydralazine treatment in spontaneously hypertensive rats. Circ Res. 1989;65:1127-36.
42. Frohlich ED, Sasaki O. Dissociation of changes in cardiovascular mass and performance with angiotensin converting enzyme inhibitors in Wistar-Kyoto and spontaneously hypertensive rats. J Am Coll Cardiol. 1990;16:1492-9.